BIOTECanada GoldLeaf Award 2010 (Early Stage Company of Year)

http://www.biotech.ca/about/gold-leaf-awards/past-awards/emerging-company-health/

https://www.fiercebiotech.com/biotech/biotech-industry-recognises-its-top-performers-gold-leaf-awards-honour-canadian-biotech

Finalist E&Y 2009 (Pacific Region)

https://www.bcbusiness.ca/the-2009-runners-up

iCo/IONIS (formerly Isis) partnership

http://ir.ionispharma.com/news-releases/news-release-details/isis-pharmaceuticals-licenses-antisense-drug-ico-therapeutics

iCo/CAT (now AstraZeneca MedImmune) partnership

https://www.biospace.com/article/releases/cambridge-antibody-technology-group-plc-licenses-monoclonal-antibody-cat-213-for-treatment-of-allergy-disorders-to-ico-therapeutics-inc-/

iCo/JDRF partnership

https://www.jdrf.ca/news-and-media/press-room/ico-therapeutics-and-jdrf-team-up/

Gates/Canada oral Amphotericin B funding

https://www.newswire.ca/news-releases/ico-therapeutics-receives-funding-from-the-government-of-canada-for-the-pre-clinical-and-clinical-development-of-its-oral-amphotericin-b-delivery-system-for-the-treatment-of-hivaids-510307301.html

Industry Leaders Involved with iCo

UBC President former CSO of iCo

https://vancouversun.com/news/local-news/ubc-expected-to-appoint-santa-ono-as-new-president

Company ran an almost 200 patient Phase 2 study (in conjunction with JDRF) with 5 FTEs, an enormous undertaking

https://www.ophthalmologytimes.com/modern-medicine-feature-articles/ico-completes-phase-ii-ideal-dme-study-enrollment

Richard Barker – on Celgene board

https://www.celgene.com/about/leadership/board-of-directors/

Noel Hall – Aspreva co-founder

https://www.theglobeandmail.com/report-on-business/biotech-veterans-cash-in-on-success-with-aspreva-sale/article18147679/

Doug Janzen, former CEO Cardiome, $800M Merck deal

https://www.bcbusiness.ca/cardiome-makes-bc-pharma-history

Dr. Santa Ono, CSO

Current and Previous Deals